Journals / Bakırköy Tıp Dergisi / 2019 / Cilt: 15 - Sayı: 1

Upper Extremity Problems and Quality of Life in Patients with Breast Cancer

Meme Kanserli Hastalarda Üst Ekstremite Sorunları ve Yaşam Kalitesi

Pages
29–37
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that 54.7% of the patients were applied modified radical mastectomy and axillary dissection, and average time passed after surgery 11.27±10.00 months.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The study was conducted to determine upper extremity problems and quality of life in patients with breast cancer who underwent breast surgery and axillary dissection.
📊
Key Findings & Data:Methods: This descriptive and cross-sectional research was included 64 patients who admitted for outpatient clinic between 01.01.2015-01.01.2016 in university hospital in western of Turkey and previously undergone surgery for breast cancer.
💡
Conclusion & Impact:It was found that 54.7% of the patients were applied modified radical mastectomy and axillary dissection, and average time passed after surgery 11.27±10.00 months.
🔬Design:Survey & Empirical Study
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The study was conducted to determine upper extremity problems and quality of life in patients with breast cancer who underwent breast surgery and axillary dissection. Methods: This descriptive and cross-sectional research was included 64 patients who admitted for outpatient clinic between 01.01.2015-01.01.2016 in university hospital in western of Turkey and previously undergone surgery for breast cancer. The data was collected personal information form, Shoulder Pain and Disability Index (SPADI) the Shortened Disabilities of the Arm, Shoulder and Hand Questionnaire (Q-DASH), Breast Cancer Module Quality of Life Scale (EORTC QLQ-BR23) and Short Form-36 (SF-36). Statistical analyses were performed using descriptive statistics, Chi Ssquare test, Mann Whitney U test, Kruskal Walles test and the Spearman’s correlation coefficient. Results: Mean age of the study group was 52.36±12.25 years. It was found that 54.7% of the patients were applied modified radical mastectomy and axillary dissection, and average time passed after surgery 11.27±10.00 months. Affected arm had shoulder pain (53.1%), restrictions on shoulder (51.6%) and lymphedema (21.9%).It was determined that patients were received low scores from SPADI and Q-DASH, and SF-36 physical and mental summary scores of below the average. The EORTC QLQ-BR23 functional status and symptom subscales scores of patients were low. Conclusion: It was seen that patients’ quality of life was low, their functional status was poor, and cancer-related symptoms to be less. The working with multidisciplinary team on preoperative and postoperative will help prevent complications and increase the quality of life.

Özet

Amaç: Araştırma meme cerrahisi ve aksiller diseksiyon yapılan meme kanserli hastalarda üst ekstremite sorunları ve yaşam kalitesinin belirlenmesi amacıyla yapıldı. Yöntemler: Tanımlayıcı-kesitsel türdeki bu araştırmaya Türkiye’nin Batı bölgesindeki bir üniversite hastanesine 01.01.2015-01.01.2016 tarihleri arasında polikliniğe başvuran ve daha önce meme kanseri nedeni ile ameliyat yapılmış 64 hasta dahil edildi. Veriler kişisel bilgi formu, Omuz Ağrı ve Disabilite İndeksi (SPADI), Kısa Kol, Omuz ve El Sorunları Anketi (Q-DASH), EORTC QLQ-BR23 ve SF-36 kullanılarak toplandı. Verilerin analizinde tanımlayıcı istatistikler, ki kare testi, Mann Whitney U testi, Kruskall Wallis testi ve Spearman korelasyon analizi kullanıldı. Bulgular: Araştırma grubunun yaş ortalaması 52.36±12.25 yıldır. Hastaların %54.7’sine modifiye radikal mastektomi ve aksiler diseksiyon uygulandığı, ameliyattan sonra ortalama 11.27±10.00 ay geçtiği saptandı. Grubun %53.1’inde etkilenen kolda omuz ağrısı, %51.6’sının omuzda kısıtlılığı olduğu ve %21.9’unda lenfödem geliştiği belirlendi. Hastaların SPADI ve Q-DASH ölçeklerinden düşük, SF-36 fiziksel ve mental özet skorlarından ortalamanın altında puan aldıkları bulundu. EORTC QLQ-BR23 fonksiyonel durum ve semptom alt boyutundan düşük puan aldıkları belirlendi. Sonuç: Hastaların yaşam kalitelerinin düşük, fonksiyonel durumlarının kötü ve kansere bağlı semptomlarının daha az olduğu görüldü. Ameliyat öncesi ve sonrası multidisipliner bir ekip ile çalışılması oluşabilecek komplikasyonların önlenmesi ve yaşam kalitelerinin arttırılmasına yardımcı olacaktır.

🔖

Cite This Article

YILMAZ, E., COŞKUN, T. (2019). Upper Extremity Problems and Quality of Life in Patients with Breast Cancer. Bakırköy Tıp Dergisi, Cilt: 15 - Sayı: 1, 29–37. https://ajindex.com/articles/131927

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Skuta GL, Parrish RK II. Wound healing in glaucoma filtrating surgery. Surv Ophthalmol 1987;32:149-70.
  2. Costa VP, Speath GL, Eiferman RA, Orengo-Nania S. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg 1993;24:152-70.
  3. Singh P, Singh A. Mitomycin-C use in ophthalmology. J Pharm 2013;3:12-4. Bergstrom T,Wilkinson W, Skuta G. The effects of subkonjunctival mitomycin-C on glaucoma filtration surgery in rabbits. Arch Ophthalmol 1991;109:1725-30.
  4. Shields MB, Scroggs MW, Sloop CM, Simmons RB. Clinical and histopathological observations concerning hypotony after trabeculectomy with adjunctive mitomycin C. Am J Ophthalmol 1993;116:673-8. Hollo G. Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules. Dev Ophthalmol 2012;50:79-89.
  5. El Sayyad F, Belmekki M, Helal M, Khalil M, El-Hamzawey H, Hisham M. Simultaneous subkonjunctival and subscleral mitomycin C application in trabeculectomy. Ophthalmology 2000;107:298-301.
  6. Hitchings RA, Grierson I. Clinicopathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc U K 1983;103:84-8.
  7. You YA, Gu YS, Fang CT, Ma XQ. Long term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy. J Glaucoma 2002;11:110-8.
  8. Romero P, Hirunpatravong P, Alizadeh R, Kim EA, Nouri-Mahdavi K, Morales E, et al. Trabeculectomy with Mitomycin-C: Outcomes and Risk Factors for Failure in Primary Angle-Closure Glaucoma. J Glaucoma 2018;27:101-7. Akarsu C. Yüksek riskli glokom cerrahisinde düşük doz 5-FU ile MMC uygulamalarının uzun dönem sonuçları. T Klin Oftalmoloji 2003,12:192-9.
  9. S Khouri A, Huang G, Y Huang L. Intraoperative Injection vs Sponge-applied Mitomycin C during Trabeculectomy: One-year Study. J Curr Glaucoma Pract 2017;11:101-6.
  10. Robin AL, Ramakrishnan R, Krishnadas R, Smith SD, Katz JD, Selvaraj S, et al. A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol 1997;115:969-74.
  11. Neelakantan A, Rao BS, Vijaya L, Grandham SB, Krishnan N, Priya VS, et al. Effects of concentration and duration of application of mitomycin C in trabeculectomy. Ophthalmic Surg 1994;25:612-5. Rasheed el-S. Initial trabeculaectomy with intraoperative mitomycin C application in primary glaucomas. Ophthalmic Surg Lasers 1999;30:360-6. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by by local application of mitomycin-C. Trans Asia Pac Ac